Categorii
Informatii

Exozomi - DA-X - fiola 165 mg - 10 miliarde exozomi , glutathion , acid tranexamic


Exozomi - DA-X - fiola 165 mg - 10 miliarde exozomi , glutathion , acid tranexamic


Comanda instant Exozomi - DA-X - fiola 165 mg - 10 miliarde exozomi , glutathion , acid tranexamic

Exozomi - DA-X - fiola 165 mg - 10 miliarde exozomi , glutathion , acid tranexamic

CICA EXOSOME

Cica exosomes, plant exosomes, can pass through cell membranes and have biocompatibility
with mammalian cells.
Compared to synthetic nanomaterials, when reacting to normal host cells, immune or
inflammatory responses. It does not induce toxicity, immunogenicity, or allergy problems.
Passes the blood-brain barrier (BBB) but does not cross the placenta
Applicable to pregnant women as it does not affect the fetus (can deliver drugs as a carrier)

Tranexamic Acid

In the epidermis, keratinocytes are inhibited from stimulating melanocytes,
and as a result, the production of melanin is reduced.
Anti-inflammatory and anti-allergic effect

Glutathione

Powerful antioxidant, anti-aging
Inhibition of melanin production in the skin

--------------------------------

There are about 10 billion high-purity pure exosomes in one bottle

--------------------------------

It is extracted safely through patented technology and is more
Exosomes showing 10-fold higher purity and efficiency

--------------------------------

Only pure exosomes based on 100% culture
medium, using an exosome extraction method

--------------------------------

Perfect separation and purification of exosomes using two-step
separation and purification technology.

--------------------------------

Uses plant exosomes derived from cicathat have completed verification 
of exosomes that have confirmed active ingredients and CD mark

--------------------------------










Fii primul care evalueaza acest produs
Pentru a evalua acest produs este necesar sa fii autentificat. > Click aici
Mesaj clienti
Website detinut de Aesthetic & Medical Distribution S.R.L., CIF: RO35621124, Reg.Com: J40/1836/2016